ZIOPHARM ONCOLOGY INC·4

May 24, 5:11 PM ET

Cooper Laurence James Neil 4

4 · ZIOPHARM ONCOLOGY INC · Filed May 24, 2018

Insider Transaction Report

Form 4
Period: 2018-05-05
Cooper Laurence James Neil
Chief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    2018-05-05$4.41/sh123,333$543,8991,266,063 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION